Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA) | MicrobiomeTrials← Back to trialsNCT03092505
Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)
CompletedOBSERVATIONAL
Trial Details
Start: 2018-06-15Est. Completion: 2021-02-01
Enrollment target: 190 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Rakai, Kalisizo, and Villa Maria Hospital, Kalisizo, Uganda
Other microbiome trials you might be interested in
Lymphoproliferative DisorderHHV-8MalignancyHIV
This study will gain information about a rare disorder called KSHV-associated multicentric Castleman's disease (MCD). KS…
Bethesda, United StatesEst. completion Oct 1, 2026
Post-acute Sequelae of COVID-19Long COVID
The purpose of this research study is to test if the combination of three drugs, valacyclovir, celecoxib, and Paxlovid w…
New York, United StatesEst. completion Jun 30, 2028